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Abstract
Given the largely prefrontostriatal neuropathogenesis of HIV-associated neurobehavioral deficits, it is often
presumed that HIV infection leads to greater impairment on letter versus category fluency. A meta-analysis of the
HIV verbal fluency literature was conducted (k5 37, n5 7110) to assess this hypothesis and revealed generally
small effect sizes for both letter and category fluency, which increased in magnitude with advancing HIV disease
severity. Across all studies, the mean effect size of category fluency was slightly larger than that of letter fluency.
However, the discrepancy between category and letter fluency dissipated in a more conservative analysis of only
those studies that included both tests. Thus, HIV-associated impairments in letter and category fluency are of similar
magnitude, suggesting that mild word generation deficits are evident in HIV, regardless of whether traditional letter
or semantic cues are used to guide the word search and retrieval process (JINS, 2007, 13, 183–189.)
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INTRODUCTION
Although HIV RNA is detectable throughout the brain, HIV-
associated neuropathologies are most frequently evident in
the basal ganglia, frontal neocortex, hippocampus, and white
matter (Gonzalez-Scarano & Martin-Garcia, 2005). Corre-
sponding cognitive deficits are commonly observed in areas
of motor control, information processing speed, working
memory, executive functions, and episodic memory (Reger
et al., 2002). Impairment in verbal fluency is also common
in persons infected with HIV (White et al., 1997). Verbal
fluency requires rapid, self-initiated search and retrieval
from lexico-semantic memory stores to orally generate words
beginning with a particular letter or belonging to a specific
semantic category (e.g., animals). Although verbal fluency
taxes both frontal and temporal systems (Parks et al., 1988),
letter fluency is historically associated with executive func-
tions and frontal systems, whereas category fluency is more
closely tied to semantic memory and the medial temporal
lobes (Henry & Crawford, 2004a). Whether HIV-associated
neuropathology produces a differential impairment in letter
and category fluency is not known.
HIV-associated verbal fluency deficits are customarily
presumed to be driven by prefrontostriatal neuropatholo-
gies (Hestad et al., 1993). Accordingly, it is often asserted
that individuals with HIV evidence differential impairment
on letter versus category fluency. In fact, it was recently
reported that 26% of HIV studies demonstrate letter flu-
ency deficits versus only 13% for category fluency (Woods
et al., 2005). However, this qualitative review did not report
inclusion0exclusion criteria, calculate effect sizes, examine
disease effects, or consider results from only those studies
that included both letter and category fluency tasks. There-
fore, this study aimed to systematically review the verbal
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fluency literature in HIV to investigate possible differential
impairments in letter and category fluency. Our approach to
hypothesis generation was informed by recent meta-analyses
showing that, while category fluency is preferentially
impaired in conditions with prominent temporolimbic neuro-
pathology (e.g., focal temporal lesions; Henry & Crawford,
2004a), both letter and category fluency are impaired with
frontal systems damage (e.g., focal frontal lesions; Henry
& Crawford, 2004a), which refutes the aforementioned, long-
held convention in neuropsychology.
In accordance with this literature and the preferential
neurotoxic effects of HIV on prefrontostriatal circuits, one
of two outcomes was anticipated: (1) HIV infection is asso-
ciated with differentially greater deficits in letter versus
category fluency; or (2) HIV is associated with comparable
impairment in letter and category fluency. A third, arguably
less tenable possibility is that HIV is associated with greater
category fluency deficits. Indeed, hippocampal pathology
predicts HIV-associated cognitive impairment (Moore et al.,
2006) and a few HIV studies have shown preferential def-
icits in category fluency (Levin et al., 1992). Finally, con-
sidering prior research suggesting that neuropsychological
functions generally worsen with advancing HIV disease
(Reger et al., 2002), we hypothesized that disease progres-
sion would be associated with more severe verbal fluency
deficits.
METHODS
A preliminary search using key terms such as neuropsychol-
ogy, cognition, executive, verbal fluency (e.g., letter flu-
ency, semantic fluency, COWAT), HIV, and AIDS was
conducted in the PubMed, PsychInfo, and ISI Web of Sci-
ence databases for dates between January 1985 and August
2005. Manual searches of the reference sections of relevant
articles and the tables of contents of several HIV and neuro-
science journals (e.g., AIDS, Neuropsychology, and Neurol-
ogy) were also performed to identify any studies that may
have been omitted from the electronic database query.
All articles were manually reviewed to determine whether
they met the following inclusion criteria: (1) published in
English in peer-reviewed journals; (2) assessed English-
speaking adults with a standardized verbal fluency test;
(3) included participants with documented HIV infection
and without other severe neurologic or psychiatric illness
(e.g., psychosis); (4) provided sufficient verbal fluency data
from which to derive precise effect sizes; and (5) included a
seronegative comparison group without severe neurologic
or psychiatric illnesses. All eligible studies published by
the same group of authors were carefully reviewed to mini-
mize the inclusion of overlapping data from a single HIV
cohort. A total of 37 studies with 7110 participants, includ-
ing 4090 HIV seropositive and 3020 seronegative partici-
pants, were deemed eligible for inclusion. All data included
in this manuscript was obtained in compliance with institu-
tional regulations.
The following information was extracted from each study:
(1) HIV disease (i.e., seronegative, asymptomatic, symp-
tomatic, and AIDS) and treatment characteristics; (2) demo-
graphic variables (e.g., age and education); (3) verbal fluency
task; (4) sample size; and (5) summary statistics for the
calculation of effect sizes. Participants’ demographic, dis-
ease, and treatment characteristics are listed in Table 1.
Data Analysis
An unbiased estimation (Cohen’s d; Cohen, 1988) was cal-
culated separately for letter and category fluency in each
study, in which the effect size was weighted by a sample
size based constant (Hedges & Olkin, 1985). Collapsed
weighted means and pooled standard deviations based on
HIV serostatus were calculated for studies that reported
only subgrouped samples (e.g., age-based groups). Effects
were pooled and weighted to obtain a mean estimate for
calculation of a random effects meta-analytic model (Shad-
dish & Haddock, 1994).
Analysis of continuous outcomes involved comparing
standardized differences in means for HIV1 and HIV2
groups (Hedges & Olkin, 1985). Standardization allowed
the study results to be transformed to a common scale (stan-
dard deviation units), which assisted pooling (Hedges &
Olkin, 1985). Adjustments were made to correct for upward
bias of effect size estimation in small samples. Standard-
ized mean differences were calculated and analyzed for each
study. In particular, d 5 ~Mh 2 Mc !/S, where Mh and Mc
were the mean verbal fluency scores for HIV1 and HIV2
groups, respectively, and S was the standard deviation for
the pooled sample (Shaddish & Haddock, 1994). The vari-
ance for each d value was then calculated and used to deter-
mine a weighting factor for the unbiased effect size.
Effect sizes were disaggregated to define groups sharing
a common population effect size. Cochran’s Q statistic
(Cochran, 1954) was computed by summing the squared
deviations of each study’s estimate from the overall meta-
analytic estimate, weighting each study’s contribution in
the same manner as in the meta-analysis (Hedges & Olkin,
1985). Subsequently, the Q statistic was compared with a
Table 1. Participants’ demographic data and HIV
disease characteristics
HIV1 HIV2
K N Mean (SD) N Mean (SD)
Age 35 4009 35.88 (6.92) 2968 36.16 (8.23)
Education 28 3596 14.83 (2.34) 2614 15.72 (2.27)
% Male 36 4078 98.23 3008 96.70
% AIDS 34 4010 9.52
% ART 13 2392 13.7
CD4 15 2665 487.50 (256.52)
Note. K 5 number of studies; N 5 number of participants; ART 5 anti-
retroviral therapy; CD45 CD4 lymphocyte count.
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x2 distribution with k-1 degrees of freedom (where k is the
number of studies). Given apparent heterogeneity ( p’s ,
.10; Lau et al., 1997), data analysis was performed using a
random effects model (Shaddish & Haddock, 1994), which
assumes a different underlying effect for each study that is
considered as an additional source of variation (Fleiss &
Gross, 1991). Furthermore, the random effects model prof-
fers broader confidence intervals around the point estimate
and includes an extra term in the variance (DerSimonian &
Laird, 1986). Finally, computation of the significance of
the difference between the letter and category fluency effect
sizes involved Z score conversions and an estimate of the
standard error of difference between the two effect sizes.
Next, the difference between the two Z scores was divided
by the standard error (Snedecor & Cochran, 1989).
RESULTS
Table 2 displays descriptive statistics for the weighted mean
effect sizes. Letter fluency was examined in 91.9% (k5 34;
n5 6597) of the 37 eligible studies, of which 47% used the
letters FAS, 6% CFL, and 6% PRW (41% did not specify).
Of the 41.2% (k514; n5 2092) that included a measure of
category fluency, 43% used only animals, while 43% used
both animals and an additional category (e.g., supermarket
items), and 7% used food categories (7% did not specify).
Both letter and category fluency were examined in 27.0%
of the eligible studies (k5 10; n5 1535).
The mean effect sizes for both letter and category flu-
ency across all studies (k 5 37) and for those studies that
included both tasks (k 5 10) were small, but statistically
significant (see Table 2). These effect sizes indicate an
approximate overlap of 80% in the distributions of verbal
fluency scores in the HIV1 and HIV2 groups (Zakzanis,
2001). The potential dampening effects of unpublished or
omitted studies were evaluated using fail-safe N technique
(Rosenthal, 1979). Results showed that 60 letter fluency
and 195 category fluency studies equal to the average size
of those in our meta-analysis and showing no HIV effect
would be required to lower the observed effect sizes below
the threshold of statistical significance. Across all studies,
the mean effect size of category fluency was significantly
larger than that which was observed for letter fluency, p ,
.01. However, when a more rigorous analysis was under-
taken of only those studies that included both tests, there
was no significant discrepancy between letter and category
fluency effect sizes, p5 .58.
Figure 1 displays effect sizes by HIV disease stage for
studies that clearly defined their HIV sample as belonging
to specific disease stages (e.g., CDC, 1992) and contained
either letter (k5 24) or category fluency (k5 9). These data
show that medically asymptomatic subjects demonstrated
smaller deficits in both letter (d52.10) and category (d5
2.24) fluency as compared with those subjects with medi-
cally symptomatic disease (letter fluency d 5 2.36; cat-
egory fluency d52.27) or AIDS (letter fluency d52.44;
category fluency d52.34). This analysis was not repeated
for those studies that contained both letter and category
fluency measures due to the paucity of studies available for
inclusion.
Given our sampling error corrections, substantive hetero-
geneity may exist across studies. However, the observed
heterogeneity was not attributable to extreme values alone
as only one outlier was identified (i.e., age in HIV1 group).
Removal of this outlier did not change the basic pattern of
results observed and, therefore, the study was retained in
the analysis. Correlations between effect size and possible
moderators [i.e., age, education, and antiretroviral thera-
pies (ART)] were not significant (all p’s . .10). Further-
more, semipartial correlations did not reveal any significant
associations between effect size and (1) education (control-
ling for ART and age); (2) age (controlling for education
and ART); or (3) ART (controlling for education and age;
all p’s . .10).
DISCUSSION
Findings from this meta-analytic review revealed that HIV
infection is associated with generally small, but significant
deficits in verbal fluency. When all eligible studies were
considered, category fluency effects were surprisingly larger
than those observed for letter fluency. This finding ran con-
trary to our primary hypotheses, but was nevertheless com-
mensurate with research indicating that HIV-associated
Table 2. Mean effect sizes for letter and category fluency
HIV1 HIV2 95% CIs of mean
K N N M SE Var Lower Upper Q
All Studies
Letter Fluency 34 3749 2848 2.20 .045 .002 2.29 2.11 68.36*
Category Fluency 14 1330 762 2.36 .077 .006 2.51 2.21 27.55*
Studies with both fluency tests
Letter Fluency 10 971 564 2.26 .098 .010 2.45 2.07 22.38*
Category Fluency 10 971 564 2.31 .066 .004 2.44 2.18 11.12*
Note. Var5 variance; CI5 confidence interval.
*p , .10.
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cognitive deficits are related to hippocampal neuropathol-
ogy (Moore et al., 2006), which may preferentially disrupt
category fluency performance (e.g., Henry & Crawford,
2004a). However, a more rigorous comparison of only those
studies in which both verbal fluency tasks were adminis-
tered was undertaken to ensure that discrepancies in the
demographic and clinical characteristics of the variable study
samples were not contaminating this unexpected finding.
Results of this secondary analysis revealed no statistically
significant differences between letter and category fluency.
Thus HIV-associated impairments in letter and category flu-
ency appear to be of similar overall magnitude, suggesting
that mild word generation deficits are evident in HIV regard-
less of the particular lexical or semantic cue used to guide
word search and retrieval.
Although the precise cognitive and neural substrates of
HIV-associated verbal fluency deficits remain to be deter-
mined, the results of this meta-analysis raise interesting
hypotheses that may guide future research. One possibility
is that both letter and category fluency deficits in HIV dis-
ease reflect generalized bradyphrenia driven by diffuse
neuropathology. As noted above, HIV-associated neuropa-
thologies are evident throughout brain parenchyma, includ-
ing cerebral white matter, basal ganglia, and the hippocampus
(Gonzalez-Scarano & Martin-Garcia, 2005). In support of
this contention, comparable deficits in letter and category
fluency were reported in meta-analyses of traumatic brain
injury and multiple sclerosis, two conditions associated with
diffuse neuropathology at the group level (Henry & Craw-
ford, 2004b; Henry & Beatty, 2006). Another possibility is
that HIV-associated verbal fluency deficits reflect execu-
tive dyscontrol of search and retrieval from lexico-semantic
memory stores, perhaps of a more frontostriatal neuropatho-
genesis. For example, Hestad et al. (1993) found a negative
correlation between verbal fluency and caudate atrophy in
HIV-infected individuals. In addition, analyses of the com-
ponent processes of HIV-associated verbal fluency deficits
has revealed impairments in switching (i.e., a marker of
executive function entailing the number of times an indi-
vidual disengages from one lexico-semantic cluster and
switches to another), but not clustering (i.e., the average
number of consecutively generated words within a lexico-
semantic category that demonstrates validity as an indica-
tor of medial temporal lobe integrity; Millikin et al., 2004;
Woods et al., 2004). Nevertheless, we cannot rule out a
third possibility, which is that HIV-associated letter and
category fluency deficits have relatively separable neural
mechanisms, despite being of similar severity. For instance,
frontostriatal pathology may primarily underlie letter flu-
ency impairment, whereas temporolimbic pathology may
play a larger role in the category fluency deficit. Prospec-
tive studies that incorporate analyses of component cogni-
tive processes and regional measures of HIV-associated
neuropathology are needed to clarify the cognitive and neu-
ral mechanisms of verbal fluency deficits in HIV.
Consistent with past research indicating negative effects
of HIV disease progression on cognition (e.g., Reger et al.,
2002), the magnitude of verbal fluency deficits increased
with advancing HIV disease severity. The largest effect sizes
were evident in persons with AIDS, suggesting an increased
neurotoxic burden associated with immunocompromise (e.g.,
Stout et al., 1998). Despite prior evidence of the beneficial
effects of immune reconstitution and ART on cognition (e.g.,
Martin et al., 1998), as well as a possible interaction between
highly active ART (HAART) and disease status specifi-
cally on verbal fluency (Millikin et al., 2004), our moder-
ator analyses revealed no significant effects of HAART. Of
note, the studies used in this meta-analysis include data
from the current and pre-HAART eras, which may suggest
that the overall prevalence and severity of letter and cat-
egory fluency impairment did not change significantly after
the introduction of HAART. In fact, a recent meta-analysis
of studies published in the pre-HAART era showed similar
language fluency effect sizes in nondemented symptomatic
and AIDS groups as were identified in the current investi-
gation (Cysique et al., 2006).
Fig. 1. Box and whisker plots showing the effect sizes for letter
(A) and category (B) fluency by HIV disease stage.
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Nevertheless, the external validity of these cross-sectional
moderator analyses remains speculative and is hindered by
the small number of eligible studies that provided detailed
information regarding treatment status. Unfortunately, mod-
erator analyses of several other important HIV disease cofac-
tors (e.g., hepatitis C infection, substance abuse, and affective
disorders) and demographic variables (e.g., ethnicity, IQ,
and socioeconomic status) were not possible due to the lack
of consistent data reporting across studies. The current study
results must be interpreted cautiously because the aforemen-
tioned factors are prevalent in HIV-infected cohorts and
may exert an adverse influence on neuropsychological func-
tioning (Woods & Grant, 2005). In particular, the predom-
inately well-educated and male samples from which these
data were derived represent a significant limitation to the
generalizability of these findings, especially considering the
growing HIV epidemic in women and minorities (CDC,
2005). Investigators are, therefore, encouraged to include
these important, descriptive variables in all future studies
of cognition in HIV.
In summary, this meta-analysis expands our understand-
ing of HIV-associated neurocognitive disorders by provid-
ing the first systematic review of the verbal fluency literature
in HIV infection. Results revealed generally small and com-
parable deficits in letter and category fluency. Although
the observed deficits were small, these findings may be of
clinical relevance, particularly for persons with advanced
disease who are at risk for more severe verbal fluency impair-
ment. HIV-infected individuals with deficits in verbal flu-
ency, as well as in other tests with strong processing speed
and executive function demands, may be more likely to
experience poor health-related quality of life and problems
with instrumental activities of daily living (IADLs), such
as treatment adherence, automobile driving, and employ-
ment (e.g., Heaton et al., 2004). The development of novel
verbal fluency tasks may be worthwhile in this regard; for
example, action (verb) fluency, which was recently devel-
oped based on the hypothesized dissociation between noun
and verb processing, may be a particularly useful predictor
of IADLs in HIV. In fact, action fluency may be more sen-
sitive to HIV-associated neurocognitive impairment (Woods
et al., 2005) and provide incremental ecological validity in
predicting IADL dysfunction relative to traditional letter
and animal fluency tasks (Woods et al., 2006). Additional
research is needed to more comprehensively examine the
functional implications of HIV-associated deficits on both
traditional and novel verbal fluency tasks, as well as the
efficacy and ecological relevance of targeted pharmacolog-
ical and neuropsychological remediation strategies.
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